Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alessandro Beghini

8PUBLICATIONS
11CO-AUTHORS
Haematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Mar 28, 2025
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects.

Alessandra Trojani, Ester Pungolino, Barbara Di Camillo

|Dec 23, 2024
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS).

Alessandra Trojani, Alessandro Beghini, Luca Emanuele Bossi

|Dec 11, 2024
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial.

Roberto Cairoli, Arianna Gatti, Giovanni Grillo

|Aug 26, 2023
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting.

Luca Emanuele Bossi, Cassandra Palumbo, Alessandra Trojani

|Aug 12, 2023
Cordycepin (3'dA) Induces Cell Death of AC133<sup>+</sup> Leukemia Cells via Re-Expression of <i>WIF1</i> and Down-Modulation of <i>MYC</i>.

Nazanin Abazari, Marta Rachele Stefanucci, Luca Emanuele Bossi

|May 16, 2022
A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms.

Alessandro Beghini, Livia Leuzzi, Nazanin Abazari

Pageof 2

Frequent Collaborators

5 joint publications

Alessandra Trojani

5 joint publications

Roberto Cairoli

4 joint publications

Luca Emanuele Bossi

2 joint publications

Cassandra Palumbo

2 joint publications

Barbara Di Camillo

1 joint publications

Antonino Greco

1 joint publications

Patrizia Zappasodi

1 joint publications

Annamaria Frustaci

1 joint publications

Mariella D'adda

1 joint publications

Mauro Turrini

Frequent Collaborators

5 joint publications

Alessandra Trojani

5 joint publications

Roberto Cairoli

4 joint publications

Luca Emanuele Bossi

2 joint publications

Cassandra Palumbo

Top Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on : Mar 26, 2018

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on : Mar 29, 2017

11.7K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.1K
See more related videos

Top Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on : Mar 26, 2018

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on : Mar 29, 2017

11.7K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.1K
See more related videos